跳至主要内容
临床试验/NCT02407197
NCT02407197已完成不适用

International T1 Multicentre CMR Study

King's College London4 个研究点 分布在 3 个国家目标入组 1,629 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,629
试验地点
4
主要终点
Survival

研究概览

简要总结

Myocardial fibrosis is the fundamental substrate for the development of heart failure.

Cardiovascular magnetic resonance (CMR) allows non-invasive assessment of myocardial fibrosis based on late gadolinium enhancement (LGE) and T1 mapping.

Patients: Prospective longitudinal observational multicenter study of consecutive patients with suspected or known non-ischemic cardiomyopathy.

Imaging: Non-invasive measures of myocardial fibrosis: native T1, extracellular volume fraction (ECV) and LGE.

Primary endpoints: all cause and cardiovascular mortality.

Secondary endpoints: arrhythmic composite and HF composite endpoints.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adults > 18 years of age
  • clinical indication for CMR
  • able to provide informed consent
  • Exclusion criteria:
  • contraindications for cardiac magnetic resonance imaging due to MR unsafe devices or objects

排除标准

  • 未提供

结局指标

主要结局

Survival

时间窗: 1 year

number of deaths

次要结局

  • Rate of deaths due to cardiovascular causes(1 year)
  • Rate of HF events(1 year)
  • Rate of Arrhythmia(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eike Nagel

Global Chief Investigator

King's College London

研究点 (4)

Loading locations...

相似试验

International T1 Multicentre CMR Outcome Study | 临床试验